Medicare Enrolled
Dr. Kenneth Bookman, M.D.
Pulmonary Disease · Naples, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bookman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bookman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bookman
Dr. Kenneth Bookman is a pulmonary disease specialist in Naples, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bookman performed 1,880 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bookman received a total of $9,531 from 55 pharmaceutical and/or device companies across 422 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bookman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 35% volume in FL
$9,531 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 92562 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,880
Medicare services
Top 35% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,074 | $65 | $208 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
378 | $97 | $293 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
150 | $142 | $357 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $94 | $382 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
112 | $137 | $491 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $71 | $260 |
| New patient office visit, complex (60-74 min) | 18 | $176 | $574 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,531
Total received (2018-2024)
Avg $1,362/year across 7 years
Top 22% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
422
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,334
2023
$2,176
2022
$1,311
2021
$1,013
2020
$1,108
2019
$1,162
2018
$1,426
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$223
Regeneron Healthcare Solutions, Inc.
$163
HARMONY BIOSCIENCES LLC
$148
Insmed, Inc.
$117
GlaxoSmithKline, LLC.
$82
Merck Sharp & Dohme LLC
$79
Avadel CNS Pharmaceuticals, LLC
$75
GENZYME CORPORATION
$67
Actelion Pharmaceuticals US, Inc.
$66
INOGEN, INC.
$57
Axsome Therapeutics, Inc.
$45
Baxter Healthcare
$34
JAZZ PHARMACEUTICALS INC.
$34
Harmony Biosciences Llc
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Resmed Corp
$24
Grifols USA, LLC
$21
Paratek Pharmaceuticals, Inc.
$19
Fisher & Paykel Healthcare Inc
$19
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,618
AstraZeneca Pharmaceuticals LP
$1,580
Harmony Biosciences LLC
$896
Insmed, Inc.
$550
Regeneron Healthcare Solutions, Inc.
$434
Boehringer Ingelheim Pharmaceuticals, Inc.
$423
Actelion Pharmaceuticals US, Inc.
$348
Philips Electronics North America Corporation
$290
HARMONY BIOSCIENCES LLC
$283
Merck Sharp & Dohme LLC
$263
Advanced Respiratory, Inc
$229
Mylan Specialty L.P.
$180
Abbott Laboratories
$168
Paratek Pharmaceuticals, Inc.
$154
GENZYME CORPORATION
$154
La Jolla Pharmaceutical Company
$144
AbbVie Inc.
$126
Merck Sharp & Dohme Corporation
$103
Grifols USA, LLC
$99
United Therapeutics Corporation
$85
Avadel CNS Pharmaceuticals, LLC
$75
Shionogi Inc
$74
Baxter Healthcare
$74
Janssen Pharmaceuticals, Inc
$67
JAZZ PHARMACEUTICALS INC.
$65
ADVANCED RESPIRATORY, INC
$65
Axsome Therapeutics, Inc.
$62
Eisai Inc.
$61
Melinta Therapeutics, LLC
$58
INOGEN, INC.
$57
Circassia Pharmaceuticals Inc
$51
Fisher & Paykel Healthcare Inc
$51
PORTOLA PHARMACEUTICALS, INC.
$48
Amgen Inc.
$45
Janssen Biotech, Inc.
$42
Resmed Corp
$41
ABBVIE INC.
$40
Shire North American Group Inc
$36
Sunovion Pharmaceuticals Inc.
$33
CSL Behring
$32
Electromed, Inc.
$31
Inogen, Inc.
$31
Harmony Biosciences Llc
$31
IDORSIA PHARMACEUTICALS US INC
$31
AIMMUNE THERAPEUTICS, INC.
$24
Gilead Sciences, Inc.
$24
EISAI INC.
$23
Novartis Pharmaceuticals Corporation
$21
Genentech USA, Inc.
$18
Smith+Nephew, Inc.
$17
Jazz Pharmaceuticals Inc.
$17
Teva Pharmaceuticals USA, Inc.
$17
Chiesi USA, Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$14
PFIZER INC.
$11
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirFit · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CLEVIPREX · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · FASENRA · FISHER & PAYKEL HEALTHCARE · Fetroja · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JANUVIA · Kimyrsa · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · MITRACLIP · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PICO · Perforomist · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · Sunosi · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VOWST · Vabomere · Vest 205 Metaneb System · Volara System · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
41
County median income
$86,173
Nearest hospital to ZIP centroid (approximate)
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bookman is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bookman experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bookman performed 1,074 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bookman receive payments from pharmaceutical companies?
Yes. Dr. Bookman received a total of $9,531 from 55 companies across 422 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bookman's costs compare to other pulmonary diseases in Naples?
Dr. Bookman's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bookman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Naples
Browse pulmonary diseases in Naples ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Harmony Biosciences LLC Payments to Doctors
See all physicians who received payments from Harmony Biosciences LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology